Your account is not claimed yet. You can sign up with ORCID to claim your account.

Emma Polonio-Alcalá

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Tyrosine Kinase

Top Venues

Cancer communications (London, England)

New Therapeutic Targets Laboratory (TargetsLab)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

New Therapeutic Targets Laboratory (TargetsLab) Jan 1o 2018

Spain

Researcher :: Department of Medical Sciences of University of Girona

Publications

Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Muñoz-Guardiola, Elisabet Megías-Roda, Hector Perez-Montoyo, Marc Yeste-Velasco, Jose Alfón, Jose Miguel Lizcano, Carles Domènech, Santiago Ruiz-Martínez, Teresa Puig Miquel
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models. Cancer communications (London, England) 42 (6) (2022)
Emma Polonio-Alcalá, Marc Rabionet, Santiago Ruiz-Martínez, Sònia Palomeras, Rut Porta, Carmen Vásquez-Dongo, Joaquim Bosch-Barrera, Teresa Puig Miquel, Joaquim Ciurana
Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma. Cancers 13 (21) (2021)
Emma Polonio-Alcalá, Sònia Palomeras, Daniel Torres-Oteros, Joana Relat, Marta Planas, Lidia Feliu, Joaquim Ciurana, Santiago Ruiz-Martínez, Teresa Puig Miquel
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. Cancers 12 (5) (2020)
Emma Polonio-Alcalá, Marc Rabionet, Xavier Gallardo, David Angelats, Joaquim Ciurana, Santiago Ruiz-Martínez, Teresa Puig
PLA Electrospun Scaffolds for Three-Dimensional Triple-Negative Breast Cancer Cell Culture. Polymers 11 (5) (2019)